IQOS | Altria Group and Philip Morris USA

FDA Authorizes IQOS to be Marketed as Modified Risk Tobacco Product

The U.S. Food and Drug Administration (FDA) has given Altria Group the ok to market its heat not burn device, IQOS, as a modified...
Philip Morris International's Revenue and Stock Jumps Due to IQOS

Philip Morris International’s Revenue and Stock Jumps Due to IQOS

Philip Morris International (PMI) can thank the emerging market of heat-not-burn for not only meeting but beating recent revenue estimates. Earlier this year, the U.S....
IQOS | Altria and Philip Morris Intrnational End U.S. Commercialization Agreement

Philip Morris International to Regain Full U.S. Commercial Rights to IQOS

Altria has reached an agreement with Philip Morris International (PMI) relating to the IQOS Tobacco Heating System. Altria has revealed that it will receive...
FDA Grants Modified Risk Authorization to 22nd Century Group's VLN

FDA Grants Modified Risk Authorization to 22nd Century Group’s VLN

22nd Century Group, Inc., a leading agricultural biotechnology company that is focused on tobacco harm reduction and reduced nicotine tobacco products, has announced that...
Senators oppose application for iQOS

U.S. Senators Oppose Philip Morris International’s iQOS Application

Opposition is growing against Philip Morris International’s modified-risk application for iQOS. Ten U.S. senators–all Democrats–have sent a letter to Scott Gottlieb, the commissioner of...
Foundation for a Smoke-Free World Philip Morris International Ties

Foundation For a Smoke-Free World’s Ties to Philip Morris International Questioned

The Foundation For a Smoke-Free World has sent a letter to 344 public health researchers and groups, offering $1 billion in grants. While this...
- Advertisement -